Analyst Price Target is C$8.75
▲ +30.99% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$8.75, with a high forecast of C$9.00 and a low forecast of C$8.50. The average price target represents a 30.99% upside from the last price of C$6.68.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Aurora Cannabis. This rating has held steady since January 2025, when it changed from a Moderate Buy consensus rating.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Read More